SCHEMBL19954590

SCHEMBL19954590

O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CN(C(=O)[C@@H](Cc2ccccc2)NC2CCCC2)C/C1=C\c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.50
USP18 Q9UMW8 2/20 0.43
UCHL5 Q9Y5K5 2/20 0.43
PSMB5 P28074 1/20 0.42
MAPT P10636 2/20 0.41
ACHE P22303 1/20 0.41
BCL2 P10415 3/20 0.41
HSP90AA1 P07900 1/20 0.39
USP2 O75604 1/20 0.39
MCHR1 Q99705 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
MDM2 Q00987 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
P2RX7 Q99572 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19954682 0.98 CASP3 (0.50) CASP3USP18UCHL5PSMB5MAPT
SCHEMBL17693760 0.87 CASP3 (0.53) CASP3USP18UCHL5PSMB5MAPT
SCHEMBL25003481 0.84 CASP3 (0.50) CASP3USP18UCHL5PSMB5MAPT
SCHEMBL17693738 0.84 CASP3 (0.58) CASP3USP18UCHL5PSMB5MAPT
SCHEMBL19954680 0.83 PAX8 (0.44) PSMB5MAPTACHEHSP90AA1MEN1
SCHEMBL17693740 0.82 CASP3 (0.56) CASP3USP18UCHL5MAPTACHE
SCHEMBL21137783 0.79 TDP1 (0.44) CASP3MEN1MAPK1KMT2A
SCHEMBL25183349 0.79 CASP3 (0.46) CASP3PSMB5MAPTACHEBCL2
SCHEMBL25183347 0.79 CASP3 (0.46) CASP3PSMB5MAPTACHEBCL2
SCHEMBL25183346 0.79 CASP3 (0.46) CASP3PSMB5MAPTACHEBCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9913834-B2 Bis-benzylidine piperidone proteasome inhibitor with anticancer activity THE JOHNS HOPKINS UNIVERSITY (US) 2018-03-13 US disclosed